Lucio Barile Selected Research

Lucio Barile Research Topics

Disease

10	Myocardial Infarction 01/2021 - 02/2007
7	Heart Failure 01/2023 - 01/2008
4	Heart Diseases (Heart Disease) 01/2020 - 02/2007
3	Infarction (Infarctions) 01/2019 - 02/2007
2	COVID-19 01/2022 - 05/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2021
2	Inflammation (Inflammations) 02/2021 - 01/2020
2	Cardiotoxicity 01/2021 - 01/2020
2	Neoplasms (Cancer) 01/2021 - 01/2021
2	ST Elevation Myocardial Infarction 01/2020 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 07/2007
2	Cicatrix (Scar) 01/2019 - 01/2018
1	Hypertrophy 01/2023
1	Proteinuria 01/2023
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Synucleinopathies 01/2022
1	Tauopathies 01/2022
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022
1	Cognitive Dysfunction 01/2022
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022
1	Corticobasal Degeneration 01/2022
1	Brain Ischemia (Cerebral Ischemia) 10/2021
1	Transient Ischemic Attack 10/2021
1	Melanoma (Melanoma, Malignant) 10/2021
1	Hyperaldosteronism (Conn Syndrome) 01/2021
1	Brain Death (Brain Dead) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Infertility (Sterility) 01/2021
1	Hypoxia (Hypoxemia) 12/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Heart Valve Diseases (Valvular Heart Disease) 01/2020
1	Necrosis 01/2020
1	Left Ventricular Dysfunction 01/2020
1	Reperfusion Injury 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Coronary Occlusion 01/2018
1	Atrophy 01/2017
1	Pulmonary Hypertension 10/2014
1	Muscular Diseases (Myopathy) 03/2013
1	Neuroblastoma 11/2004

Drug/Important Bio-Agent (IBA)

8	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2023 - 01/2015
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
3	Surface Antigens (Surface Antigen)IBA 10/2021 - 01/2021
2	Conditioned Culture MediaIBA 01/2023 - 01/2020
2	AntigensIBA 01/2022 - 05/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2020
2	human ERBB2 proteinIBA 01/2021 - 01/2020
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2020
2	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2013 - 02/2007
1	CreatinineIBA 01/2023
1	Angiotensin IIIBA 01/2023
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 01/2023
1	Myosins (Myosin)IBA 09/2022
1	ImmunosorbentsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	Thromboplastin (Tissue Factor)IBA 01/2022
1	CoagulantsIBA 01/2022
1	EnzymesIBA 01/2022
1	tau Proteins (tau Protein)IBA 01/2022
1	Chondroitin Sulfate ProteoglycansIBA 10/2021
1	EndotoxinsIBA 01/2021
1	AnthracyclinesIBA 01/2021
1	TicagrelorIBA 12/2020
1	Chemokine CCL5IBA 01/2020
1	AlarminsIBA 01/2020
1	EpitopesIBA 01/2020
1	TroponinIBA 01/2020
1	Cytochromes c (Cytochrome c)IBA 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019
1	Platelet Activating FactorIBA 01/2019
1	Phosphates (Orthophosphate)IBA 01/2019
1	CytokinesIBA 01/2019
1	Ranolazine FDA Link 10/2014
1	Sarcoglycans (beta Sarcoglycan)IBA 03/2013
1	Saline SolutionIBA 06/2011
1	Ferritins (Ferritin)IBA 06/2011
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2004

Therapy/Procedure

8	Therapeutics 01/2021 - 02/2007
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018 - 01/2008
2	Intravenous Administration 01/2021 - 01/2020
1	Cardiac Resynchronization Therapy 01/2023
1	Heart Transplantation (Grafting, Heart) 01/2021
1	Intravenous Injections 01/2019
1	Transplantation 01/2017
1	Autologous Transplantation 07/2007